Analyst Price Target is $11.50
▲ +197.93% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Larimar Therapeutics in the last 3 months. The average price target is $11.50, with a high forecast of $16.00 and a low forecast of $4.50. The average price target represents a 197.93% upside from the last price of $3.86.
Current Consensus is
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Larimar Therapeutics. This Buy consensus rating has held steady for over two years.